BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20406235)

  • 21. Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha.
    van der Heijden J; de Jong MC; Dijkmans BA; Lems WF; Oerlemans R; Kathmann I; Schalkwijk CG; Scheffer GL; Scheper RJ; Jansen G
    Ann Rheum Dis; 2004 Feb; 63(2):138-43. PubMed ID: 14722201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
    Mizuno T; Fukudo M; Terada T; Kamba T; Nakamura E; Ogawa O; Inui K; Katsura T
    Drug Metab Pharmacokinet; 2012; 27(6):631-9. PubMed ID: 22673043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
    Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J
    J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efflux protein expression in human retinal pigment epithelium cell lines.
    Mannermaa E; Vellonen KS; Ryhänen T; Kokkonen K; Ranta VP; Kaarniranta K; Urtti A
    Pharm Res; 2009 Jul; 26(7):1785-91. PubMed ID: 19384462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
    Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
    J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1).
    Kort A; Durmus S; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharm Res; 2015 Jul; 32(7):2205-16. PubMed ID: 25563977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
    Lin F; Hoogendijk L; Buil L; Beijnen JH; van Tellingen O
    Eur J Cancer; 2013 May; 49(8):2059-64. PubMed ID: 23422148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
    Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
    Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
    Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.
    Beéry E; Rajnai Z; Abonyi T; Makai I; Bánsághi S; Erdő F; Sziráki I; Herédi-Szabó K; Kis E; Jani M; Márki-Zay J; Tóth GK; Krajcsi P
    Drug Metab Pharmacokinet; 2012; 27(3):349-53. PubMed ID: 22790065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies.
    Kozłowska-Rup D; Czekaj P; Plewka D; Sikora J
    Ginekol Pol; 2014 Jun; 85(6):410-9. PubMed ID: 25029804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.
    Agarwal S; Hartz AM; Elmquist WF; Bauer B
    Curr Pharm Des; 2011; 17(26):2793-802. PubMed ID: 21827403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development.
    Sawicki WT; Kujawa M; Jankowska-Steifer E; Mystkowska ET; Hyc A; Kowalewski C
    Gene Expr Patterns; 2006 Oct; 6(7):738-46. PubMed ID: 16458078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.
    Zhang Y; Laterra J; Pomper MG
    Neoplasia; 2009 Jan; 11(1):96-101. PubMed ID: 19107236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.